FDA Inspection
Fagron Compounding ServicesFagron Compounding Services – FDA Inspection, Jun 21, 2019
Record Details
This FDA Inspection record concerns Fagron Compounding Services, with an inspection on June 21, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ec61319a-4163-4ae8-af04-a4c5f0ce681b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1093689
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.134(a)Correct labels during finishing operations
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fagron Compounding Services
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| June 28, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fagron Compounding Services
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.